In addition, there is evidence that IL-1β secretion, possibly from atypical cellular sources such as fibroblasts, contribute to severe, treatment unresponsive inflammatory bowel disease not associated with a mutation (32). The gene discussed is IL1B; the disease is inflammatory bowel disease.